Evidence map›Paper›PMID 39862144›Full record

ArticleBioanalysis2025

2024 White Paper on Recent Issues in Bioanalysis: Three Way-Cross Validation; Urine Clinical Analysis; Automated Methods; Regulatory Queries on Plasma Protein Binding; Automated Biospecimen Management; ELN Migration; Ultra-Sensitivity Mass Spectrometry (

John Wojcik, Timothy Sikorski, Jian Wang, Yue Huang, Hiroshi Sugimoto, Mike Baratta, Eugene Ciccimaro, Rachel Green, Wenying Jian, Sumit Kar and 59 more

Abstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioanalysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

69 authors.

John WojcikMerck, West Point, PA, USA.
Timothy SikorskiGlaxoSmithKline, Collegeville, PA, USA.
Jian WangCrinetics, San Diego, CA, USA.
Yue HuangRevolution Medicines, South San Francisco, CA, USA.
Hiroshi SugimotoTakeda, Cambridge, MA, USA.
Mike BarattaTakeda, Cambridge, MA, USA.
Eugene CiccimaroBristol Myers Squibb, Lawrenceville, NJ, USA.
Rachel GreenComplement Stevenage, UK.
Wenying JianJohnson & Johnson Innovative Medicine, Spring House, PA, USA.
Sumit KarWRIB, Toronto, ON, Canada.
Yeoun Jin KimAstraZeneca, Gaithersburg, MD, USA.
Michael LassmanMerck, West Point, PA, USA.
Susovan MohapatraStoke, Bostom, MA, USA.
Mark QianTakeda, Cambridge, MA, USA.
Anton I RosenbaumAstraZeneca, South San Francisco, CA, USA.
Hetal SarvaiyaAbbVie, San Mateo, CA, USA.
Yu TianAbbVie, Worcester, MA, USA.
Inna VainshteinExelixis, Alameda, CA, USA.
Long YuanBiogen, Cambridge, MA, USA.
Lin TaoSanofi, Framingham, MA, USA.
Allena JiChiesi, Boston, MA, USA.
Christopher KochanskyExelixis, King of Prussia, PA, USA.
Haibo QiuRegeneron, Tarrytown, NY, USA.
Estelle MaesAbbvie, Chicago, IL, USA.
Lin-Zhi ChenBoehringer Ingelheim, Ridgefield, CT, USA.
Megan CooleyICON, Lenexa, KS, USA.
Dawn DufieldKCASBio, Olathe, KS, USA.
Elizabeth HyerLabcorp, Madison, WI, USA.
Jay JohnsonPfizer, Andover, MA, USA.
Wenkui LiNovartis, East Hanover, NJ, USA.
Aihua LiuResolian, Berwyn, PA, USA.
Yang LuUS FDA, Silver Spring, MD, USA.
John MeissenAstraZeneca, South San Francisco, CA, USA.
Joe PalandraTakeda, Cambridge, MA, USA.
Xiaonan TangFrontage, Exton, PA, USA.
Adam VigilRegeneron, Tarrytown, NY, USA.
Wei WeiBoehringer Ingelheim, Ridgefield, CT, USA.
Stephen VinterUK MHRA, London, UK.
Yongjun XueBristol Myers Squibb, Lawrenceville, NJ, USA.
Li YangUS FDA, Silver Spring, MD, USA.
Naiyu ZhengBristol Myers Squibb, Lawrenceville, NJ, USA.
Kimberly BensonUS FDA, Silver Spring, MD, USA.
Fred McCushPfizer, Groton, CT, USA.
Zhenmin LiangVertex, Boston, MA, USA.
Lee AbberleyGlaxoSmithKline, Collegeville, PA, USA.
Matthew AndisikRegeneron, Tarrytown, NY, USA.
Marcela ArayaPfizer, Groton, CT, USA.
Seongeun Julia ChoUS FDA, Silver Spring, MD, USA.
Liliana ColliganRegeneron, Tarrytown, NY, USA.
Arindam DasguptaUS FDA, Silver Spring, MD, USA.
Markus DudekSanofi, Frankfurt, Germany.
Anna EdmisonHealth Canada, Ottawa, ON, Canada.
Sally FischerGenentech, South San Francisco, CA, USA.
Brian FolianUS FDA, Silver Spring, MD, USA.
Fabio GarofoloBRI Frontage, Vancouver, BC, Canada.
Akiko Ishii-WatabeJapan MHLW, Tokyo, Japan.
Dany IvanovaHealth Canada, Ottawa, ON, Canada.
Sonja Kwadijk-de GijselDutch IGJ, Randstad, Netherlands.
Lina LuoBristol Myers Squibb, Lawrenceville, NJ, USA.
Michael McGuinnessUK MHRA, London, UK.
Christine O 'DayPfizer, Bothell, WA, USA.
Reza Salehzadeh-AslHealth Canada, Ottawa, ON, Canada.
João Tavares NetoBrazil ANVISA, Brasilia, Brazil.
Tom VerhaegheJohnson & Johnson Innovative Medicine, Beerse, Belgium.
Katty WanPfizer, San Diego, CA, USA.
Emma WhaleUK MHRA, London, UK.
Weili YanGenentech, South San Francisco, CA, USA.
Eric YangGlaxoSmithKline, Collegeville, PA, USA.
Jinhui ZhangUS FDA, Silver Spring, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 18

Indexed as

Blood ProteinsMass SpectrometryUrinalysisAutomationBiomarkersHumansBiomarkersBlood Proteinsbioanalysisbiomarkerscell therapygene therapyimmunogenicityvaccineWRIB

Identifiers

PMID39862144
PMCPMC12054924

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.